Free tool
FAERS Monitor: Lupron Depot-Ped Kit
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020263 or its brand name (Lupron Depot-Ped Kit, Leuprolide Acetate). Reports on generic versions are filed under their own applications.
Reports
8,371
Serious
6,422
77% of reports
Hospitalization
3,097
Death reported
1,154
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fatigue456
- drug ineffective446
- off label use406
- hot flush344
- asthenia299
- death286
- fall286
- nausea270
- pneumonia261
- headache252
- injection site pain251
- prostate cancer238
- anaemia224
- diarrhoea213
- prostatic specific antigen increased198
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 86 |
| 2005 | 96 |
| 2006 | 87 |
| 2007 | 120 |
| 2008 | 353 |
| 2009 | 174 |
| 2010 | 298 |
| 2011 | 290 |
| 2012 | 389 |
| 2013 | 139 |
| 2014 | 158 |
| 2015 | 310 |
| 2016 | 328 |
| 2017 | 238 |
| 2018 | 226 |
| 2019 | 268 |
| 2020 | 273 |
| 2021 | 460 |
| 2022 | 876 |
| 2023 | 816 |
| 2024 | 772 |
| 2025 | 859 |
| 2026 | 755 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,788 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| prostatic specific antigen increasedSignal | 198 | 36.6 | 31.9 | 6,731 |
| hot flushSignal | 344 | 11.5 | 10.4 | 3,290 |
| prostate cancerSignal | 238 | 7.5 | 6.6 | 1,325 |
| anaemiaSignal | 224 | 3.0 | 2.6 | 290 |
| fallSignal | 286 | 2.2 | 1.9 | 180 |
| injection site painSignal | 251 | 2.1 | 1.8 | 137 |
| pneumoniaSignal | 261 | 2.0 | 1.8 | 137 |
| asthenia | 299 | 2.0 | 1.8 | 151 |
| fatigue | 456 | 1.5 | 1.3 | 71 |
| off label use | 406 | 1.2 | 1.1 | 10 |
| headache | 252 | 1.0 | 0.9 | 0 |
| nausea | 270 | 0.9 | 0.8 | 7 |
| drug ineffective | 446 | 0.9 | 0.8 | 12 |
| death | 286 | 0.8 | 0.7 | 10 |
| diarrhoea | 213 | 0.8 | 0.7 | 8 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.